Magnesium and Intraoperative Blood Loss in Meningioma Surgery
Status:
Completed
Trial end date:
2020-02-18
Target enrollment:
Participant gender:
Summary
Meningioma is the most common central nervous system tumor and craniotomy with tumor removal
was associated with moderate blood loss and blood transfusion. Magnesium has hypotensive
effect and probably reduce intraoperative blood loss. Whether or not magnesium sulphate can
reduce intraoperative blood loss and improve postoperative cognitive function is still
inconclusive. So the investigators conduct the randomized control trial to compare the effect
of magnesium with placebo control in blood loss and cognitive function in meningioma patient
undergoing craniotomy.